Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer

Fexuclue (fexuprazan) - Daewoong Pharma

lansoprazole - Generic mfg.

Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer (clinicaltrials.gov) - Jul 29, 2026 - P3 | N=384 | Not yet recruiting | Sponsor: Daewoong Pharmaceutical Co. LTD.
New P3 trial • Peptic Ulcer

http://clinicaltrials.gov/ct2/show/NCT07730138

Jul 29, 2026